McDermott Will & Schulte, a global law firm

Among the most active markets in private equity, the healthcare industry provides ripe investment opportunities for funds that can navigate the complex regulatory landscape. As the industry’s top-ranked law firm for health and life sciences ventures, we understand key regulatory issues, communicate clearly with regulators and counsel on the other side of the table, and close deals in a cost-effective, timely manner to maximize value.

Partnering with you to create the future of the industry

We collaborate with those at the forefront of health industry innovation to foster the unique partnerships and business ventures that are transforming healthcare. Our cross-functional legal counsel removes the false barriers that often arise between transactional and regulatory issues. Thus, we’re able to minimize due diligence redundancies, assist financing sources so that legal questions are handled appropriately, and move deals swiftly from negotiation to implementation.

Our experienced private equity team has advised on hundreds of healthcare deals covering the gamut of clinics, hospitals, inpatient/outpatient services, practice management, laboratory services, information technology, managed care, devices and supplies, business processing outsourcing, revenue cycle management and more.

We are the only firm ranked in the top tier by all of the major rankings and directories, including Chambers USA, which has named us “Health Law Firm of the Year” three times. We work hand-in-hand with our top-ranked private equity practice, which means private equity funds can rely on us as a comprehensive legal solution.

Our clients have the confidence to execute because they know they have the full weight of the leading health
care law firm behind them. We offer counsel on the full range of investment and financing activities, including growth investments and buy-and-build strategies; control, non-control and minority investments; buyouts and recapitalizations; auction processes; strategic dispositions and exit strategies; and bankruptcy, out-of-court restructurings and workouts.

Skilled at helping private equity firms and their portfolio companies acquire distressed assets, our global restructuring and insolvency team offers strategic advice on navigating the peculiarities associated with asset sales in Chapter 11 and 7 bankruptcy cases, UCC Article 9 foreclosures and out-of-court restructurings. Our clients rely on our experience when acquiring assets through a debtor’s plan of reorganization in Chapter 11 bankruptcy cases because of our skilled handling of the various associated legal complications. We’re also successful with section 363 bankruptcy sales and pursuing “stalking horse” status for our clients.

Our finance team provides critical legal services during healthcare buyout transactions. Our solid relationships with numerous lenders active in the private equity marketplace allow us to think creatively in evaluating financing approaches. We are particularly skilled at tailoring multilayered financing packages to meet the unique characteristics of each deal, thanks to our vast experience with structuring acquisitions, recapitalization, refinancing and disposition of portfolio companies, as well as transactions for add-ons and restructurings.

We also serve as general counsel for portfolio companies, advising on major transactions and day-to-day legal matters, as well as providing efficiency and continuity for platform acquisitions, bolt-on transactions, operational and compliance issues, and sales.